COMT inhibitors (The Lieber Institute For Brain Development/Boehringer Ingelheim)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCOMT inhibitors (The Lieber Institute For Brain Development/Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsSchizophreniaCognition DisordersDyskinesias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLieber Institute For Brain Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim CorpLieber Institute For Brain Development
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersDyskinesias

Other Information

ATC CodeN/A
Related LinksN/A